Aidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Nifedipine ER 60 mg tablets because they may have been mislabeled as Nicotine Polacrilex 2 mg lozenges.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling Nifedipine ER, Tablet, 60 mg, NDC 00591319401, due to a labeling error. The recall is classified as Class II by the FDA.
The specific issue is a label mixup where the Nifedipine ER tablets may have been mislabeled as NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001. The affected Nifedipine ER tablets have pedigree W003729 and an expiration date of 6/26/2014. The mislabeled product is identified by pedigree W003749 and the same expiration date.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. Consumers and healthcare providers should check their inventory for these specific NDC and pedigree numbers. If the product is found, it should be returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider if they have questions about their medication.
The recalled product
- Product
- NIFEdipine ER, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591319401.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- NIFEdipine ER
- Tablet
- 60 mg has the following codes: Pedigree: W003729
- EXP: 6/26/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nebivolol Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Tizanidine Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls GuaiFENesin ER Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateNifedipine Capsules Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Nifedipine Capsules Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateCarbamazepine ER Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateFDA Recalls GuaiFENesin ER Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22